4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001562180-19-006266
Chief Business Officer sold 4,463 shares at $16.01 ($71,453)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ISACSON CHRISTINA K. Chief Business Officer | 2019-12-24 | Sale | −4,463 | $16.01 | $71,453 | 83,786 | D |
| Open-market sales · 4,463 sh · avg $16.01 · $71,453 | |||||||
Loading xslF345X03/primarydocument.xml…